Reason for request
Inscription
Clinical Benefit
| Substantial |
Le service médical rendu par PROPOFOL PANPHARMA 10 mg/mL et 20 mg/mL en émulsion injectable (IV) est important dans les indications de l’AMM.
|
Clinical Added Value
| no clinical added value |
Ces deux spécialités, génériques de DIPRIVAN, n’apportent pas d’amélioration du service médical rendu (ASMR V, inexistante).
|
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
tzbTDF0GUEgMa4hD